Industry: Pharmaceuticals, Biotechnology
Lipid Sciences, Inc. is a development-stage biotechnology company engaged in the research and development of products and processes intended to treat major medical indications, in which lipids, or fat components, play a key role. The Company’s HDL Therapy platform (HDL Selective Delipidation and HDL Mimetic Peptides) aims to develop treatments to reverse atherosclerosis, a systemic disease of the blood vessels caused by the build-up of cholesterol-filled plaques in the vascular system and, most critically, in the coronary arteries. Regression of such plaques may have a major impact on reducing the risk of acute coronary ( www.lipidsciences.com )
Lipid Sciences , Inc.
7068 Koll Center Parkway Suite 401
Pleasanton, California 94566-3111
USA
Tel: (925) 249-4000
Fax: (925) 249-4040